Search research articles
Contact Us
Filters
Showing results (21-30 of 109) with videos related to
Page
of 11
Sort By:
Nitric Oxide : Biology and Chemistry
|
May 9, 2018
Discovery and development of sGC stimulators for the treatment of pulmonary hypertension and rare diseases
Peter Sandner, Eva-Maria Becker-Pelster, Johannes Peter Stasch
Handbook of Experimental Pharmacology
|
December 21, 2016
The Three-Decade Long Journey in Heart Failure Drug Development
Kelly S Lewis, Javed Butler, Johann Bauersachs, et al.
European Journal of Pharmacology
|
March 27, 2025
Discovery of the first isoform-specific sGC activator: Selective activation of GC-1 by runcaciguat
Svenja Stomberg, Anne Rühle, Theresa Wittrien, et al.
Pflugers Archiv : European Journal of Physiology
|
July 12, 2002
Cyclic AMP stimulates renin gene transcription in juxtaglomerular cells
Jürgen Klar, Peter Sandner, Markus W H Müller, et al.
ESC Heart Failure
|
April 27, 2026
Use of sGC stimulators in heart failure therapy - a mode of action perspective
Frank Ruschitzka, Robert Lukowski, Stefano Corda, et al.
FEBS Letters
|
September 17, 2011
Human cyclic nucleotide phosphodiesterases possess a much broader substrate-specificity than previously appreciated
Daniel Reinecke, Heike Burhenne, Peter Sandner, et al.
European Journal of Pharmacology
|
May 25, 2020
Tyrosine 135 of the β<sub>1</sub> subunit as binding site of BAY-543: Importance of the Y-x-S-x-R motif for binding and activation by sGC activator drugs
Anne Rühle, Christin Elgert, Michael G Hahn, et al.
The Journal of Sexual Medicine
|
February 21, 2013
Synergistic effects of BAY 60-4552 and vardenafil on relaxation of corpus cavernosum tissue of patients with erectile dysfunction and clinical phosphodiesterase type 5 inhibitor failure
Maarten Albersen, Loes Linsen, Hanna Tinel, et al.
Plos One
|
October 29, 2015
Effects of PDE5 Inhibitors and sGC Stimulators in a Rat Model of Artificial Ureteral Calculosis
Peter Sandner, Hanna Tinel, Giannapia Affaitati, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
April 20, 2023
The 10th International Conference on cGMP 2022: recent trends in cGMP research and development-meeting report
Andreas Friebe, Jan R Kraehling, Michael Russwurm, et al.
Page
of 11
Search research articles
Search
Showing results (21-30 of 109) with videos related to
Sort By:
Page
of 11
Nitric Oxide : Biology and Chemistry
|
May 9, 2018
Discovery and development of sGC stimulators for the treatment of pulmonary hypertension and rare diseases
Peter Sandner, Eva-Maria Becker-Pelster, Johannes Peter Stasch
Handbook of Experimental Pharmacology
|
December 21, 2016
The Three-Decade Long Journey in Heart Failure Drug Development
Kelly S Lewis, Javed Butler, Johann Bauersachs, et al.
European Journal of Pharmacology
|
March 27, 2025
Discovery of the first isoform-specific sGC activator: Selective activation of GC-1 by runcaciguat
Svenja Stomberg, Anne Rühle, Theresa Wittrien, et al.
Pflugers Archiv : European Journal of Physiology
|
July 12, 2002
Cyclic AMP stimulates renin gene transcription in juxtaglomerular cells
Jürgen Klar, Peter Sandner, Markus W H Müller, et al.
ESC Heart Failure
|
April 27, 2026
Use of sGC stimulators in heart failure therapy - a mode of action perspective
Frank Ruschitzka, Robert Lukowski, Stefano Corda, et al.
FEBS Letters
|
September 17, 2011
Human cyclic nucleotide phosphodiesterases possess a much broader substrate-specificity than previously appreciated
Daniel Reinecke, Heike Burhenne, Peter Sandner, et al.
European Journal of Pharmacology
|
May 25, 2020
Tyrosine 135 of the β<sub>1</sub> subunit as binding site of BAY-543: Importance of the Y-x-S-x-R motif for binding and activation by sGC activator drugs
Anne Rühle, Christin Elgert, Michael G Hahn, et al.
The Journal of Sexual Medicine
|
February 21, 2013
Synergistic effects of BAY 60-4552 and vardenafil on relaxation of corpus cavernosum tissue of patients with erectile dysfunction and clinical phosphodiesterase type 5 inhibitor failure
Maarten Albersen, Loes Linsen, Hanna Tinel, et al.
Plos One
|
October 29, 2015
Effects of PDE5 Inhibitors and sGC Stimulators in a Rat Model of Artificial Ureteral Calculosis
Peter Sandner, Hanna Tinel, Giannapia Affaitati, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
April 20, 2023
The 10th International Conference on cGMP 2022: recent trends in cGMP research and development-meeting report
Andreas Friebe, Jan R Kraehling, Michael Russwurm, et al.
Page
of 11